Morgan Stanley upgraded Tandem Diabetes (TNDM) to Overweight from Equal Weight.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TNDM:
- Tandem Diabetes price target raised to $60 from $58 at Barclays
- Tandem Diabetes price target lowered to $40 from $43 at UBS
- Tandem Diabetes price target lowered to $56 from $57 at Canaccord
- Tandem Diabetes price target lowered to $37 from $39 at Baird
- Tandem Diabetes Care Reports Strong Q3 Growth
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
